Efficacy and Experience of Bacteriophages in Biofilm-Related Infections.
Monica GordonPaula RamirezPublished in: Antibiotics (Basel, Switzerland) (2024)
Bacterial infection has always accompanied human beings, causing suffering and death while also contributing to the advancement of medical science. However, the treatment of infections has become more complex in recent times. The increasing resistance of bacterial strains to antibiotics has diminished the effectiveness of the therapeutic arsenal, making it less likely to find the appropriate empiric antibiotic option. Additionally, the development and persistence of bacterial biofilms have become more prevalent, attributed to the greater use of invasive devices that facilitate biofilm formation and the enhanced survival of chronic infection models where biofilm plays a crucial role. Bacteria within biofilms are less susceptible to antibiotics due to physical, chemical, and genetic factors. Bacteriophages, as biological weapons, can overcome both antimicrobial resistance and biofilm protection. In this review, we will analyze the scientific progress achieved in vitro to justify their clinical application. In the absence of scientific evidence, we will compile publications of clinical cases where phages have been used to treat infections related to biofilm. The scientific basis obtained in vitro and the success rate and safety observed in clinical practice should motivate the medical community to conduct clinical trials establishing a protocol for the proper use of bacteriophages.
Keyphrases
- candida albicans
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- antimicrobial resistance
- escherichia coli
- healthcare
- clinical trial
- randomized controlled trial
- clinical practice
- mental health
- endothelial cells
- cystic fibrosis
- public health
- physical activity
- systematic review
- genome wide
- study protocol
- gene expression
- open label
- induced pluripotent stem cells
- phase ii
- replacement therapy